Delivery Order SPE2DB24D2101-SPE2DB25FKJZB
- Not listed
- The Defense Logistics Agency awarded a $14,582.36 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with a completion date of July 31, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment, and this delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $8,812.16 and an ultimate completion date of April 22, 2025. The contract was competitively awarded with no set-aside designation. Descovy is an antiretroviral medication used in HIV treatment and prevention, reflecting the critical pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $14,102.37 to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used for HIV treatment and...
- The Defense Logistics Agency awarded a $51.4K delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside delivery order with a completion deadline of October 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV treatment and prevention, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $4,739.71 to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a pharmaceutical supply delivery from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania to the same location. Descovy is an antiretroviral medication used in...
- The Defense Logistics Agency (DLA) awarded a $35,790.27 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the open market. The contract has an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Descovy is an...
- The Defense Logistics Agency awarded a delivery order valued at $29,908.08 to AmerisourceBergen Drug Corp for 30-count units of Descovy 200-25 mg tablets. This is a firm fixed price, non-set-aside contract with a completion date of September 30, 2025, issued on September 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. Descovy...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This order, valued at $7,045.86 under a firm fixed-price contract type, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be fulfilled at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $15,009.03 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. The contract is a non-set-aside award with an ultimate completion date of December 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Descovy is an HIV prevention and treatment medication, reflecting the broader pharmaceutical supply...
- The Defense Logistics Agency awarded a competitively procured delivery order valued at $2,995.23 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets (30-count units). This firm fixed-price delivery order, issued on November 28, 2025, is expected to be completed by December 1, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating the contract was awarded through open...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKJZBDelivery Order
The Defense Logistics Agency awarded a $8,390.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 units of Descovy 200-25 mg tablets. The award, issued on April 28, 2025, with an ultimate completion date of April 29, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. Descovy is an antiretroviral medication used in HIV treatment and prevention, reflecting the pharmaceutical supply requirements across the Defense Health System. This delivery order is issued under AmerisourceBergen Drug Corp's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement extending through December 2026. The parent IDC enables the contractor to supply a broad range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare programs globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp maintains a significant portfolio of federal contracts encompassing specialty medications, vaccines, and medical supplies across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 4/28/25 |